Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1999 clinical trials
Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid Tumors

This is a randomized, open-label, dose-finding, multi-centre, phase b study to evaluate the efficacy and safety of JMT103 in patients with bone metastases from solid tumors.

  • 5 views
  • 26 Jan, 2021
  • 1 location
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

This is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion. The first part of the study is an open-label, dose escalation and the second

  • 0 views
  • 23 Apr, 2022
  • 1 location
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

chemotherapy and immunotherapy. Patients with laser ablation-accessible solid tumors are treated by thermal ablation followed immediately by an intratumoral injection of IP-001 (1 % N-dihydro-galacto

  • 2 views
  • 24 Apr, 2022
  • 2 locations
  • 0 views
  • 24 Apr, 2022
  • 1 location
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors

This is an open-labe Phase I study of BPI-28592 for the treatment of patients with solid tumors

solid tumor
  • 0 views
  • 19 Apr, 2022
A Study of EMB-02 in Participants With Advanced Solid Tumors

The primary purpose of this study is to identify the recommended Phase 2 dose(s) (RP2Ds) and schedule assessed to be safe for EMB-02 and to characterize the safety and tolerability of EMB-02 at the RP2Ds. Pharmacokinetics (PK), immunogenicity, and the anti-tumor activity of EMB-02 will also be assessed.

  • 0 views
  • 24 Apr, 2022
  • 6 locations
A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors

-CD73) in Combination with AK104 in Subjects with Advanced or Metastatic Solid Tumors.

  • 0 views
  • 29 Oct, 2021
  • 5 locations
A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

Nivolumab in participants with select advanced solid tumors.

  • 0 views
  • 13 Mar, 2022
  • 3 locations
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

cells in patients with advanced solid tumors.

  • 0 views
  • 24 Mar, 2022
  • 1 location
Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors

T-1101 (Tosylate) is a new small molecule chemical entity being developed as a potential anti-cancer therapeutic by Taivex Therapeutics Corp. T-1101 (Tosylate) is a potent anti-cancer agent in numerous human cancer cell lines. In addition, oral administration of T-1101 (Tosylate) showed tumor growth inhibition in different mouse xenograft models of …

  • 0 views
  • 09 Nov, 2021
  • 2 locations